Propanc Biopharma Inc (PPCB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,838 | -58,923 | -54,852 | -785 | -354 |
| Accounts payable and accrued liabilities | -187 | 188 | 119 | 102 | -19 |
| Other Working Capital | -908 | 1,138 | 2,002 | 305 | 69 |
| Other Operating Activity | 3,993 | 57,192 | 52,353 | 136 | 69 |
| Operating Cash Flow | $-1,939 | $-405 | $-378 | $-242 | $-236 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-3 | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -50 | 886 | 589 | 394 | 156 |
| Debt Repayment | -151 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 3,315 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -587 | -395 | -106 | -98 | 60 |
| Financing Cash Flow | $2,527 | $491 | $483 | $296 | $216 |
| Exchange Rate Effect | 5 | -95 | -75 | -60 | 8 |
| Beginning Cash Position | 12 | 21 | 21 | 21 | 21 |
| End Cash Position | 603 | 12 | 51 | 15 | 9 |
| Net Cash Flow | $591 | $-9 | $30 | $-7 | $-12 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,939 | -405 | -378 | -242 | -236 |
| Capital Expenditure | -3 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -1,942 | -405 | -378 | -242 | -236 |